That the Parliament marks Pancreatic Cancer Awareness Month, which takes place every November, and World Pancreatic Cancer Day, which falls on 19 November 2026; acknowledges the previous Members' debates on pancreatic cancer, which, it believes, have highlighted the case for the condition being treated as an urgent health priority; commends the ongoing work of charity organisations over the last 10 years to improve outcomes of what it understands is Scotland’s deadliest common cancer; recognises the progress that has been made in recent years, including promising developments in earlier diagnosis research and greater recognition of less survivable cancers; notes the view that more work is needed to secure sustainable funding for best practice national pathways for pancreatic cancer diagnosis, treatment and care, so that patients can benefit from long-term improvements; acknowledges the potential of game-changing innovations, such as the breath test for diagnosing the condition and personalised medicine, and the need for policy leads to support their integration into standard care practice; notes the view that all patients nationally should be able to benefit from the provisions of the UK-wide Rare Cancers Act 2026, including through improved access to clinical trials and new treatments; acknowledges calls for Scotland to appoint a national lead to take its work in this field forward alongside UK counterparts; believes that the last 10 years has brought greater public awareness and political attention to pancreatic cancer and notes the view that the next 10 years should deliver tangible improvements to ultimately increase survival rates and save lives across Scotland; thanks all lived experience advocates who bravely use their unique perspective to help shape and inform pancreatic cancer progress, and wishes everyone involved with Pancreatic Cancer Awareness Month every success in raising awareness of this devastating disease.
Supported by: Paul Sweeney